Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A's Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...

Related Keywords

Sandesh Seth ,Astellas Pharma ,Exchange Commission ,Oncology Lg Chem Life Sciences ,Actimaba National Cancer Institute ,Prnewswire Actinium Pharmaceuticals Inc ,Society Of Immunotherapy Cancer ,Annual Meeting ,National Cancer Institute ,Life Sciences ,Actinium Pharmaceuticals ,Nc ,